Raloxifene Alternatives Compared
| Raloxifene | Alendronate | Calcium / vitamin d |
|
|---|
| Raloxifene | Alendronate | Calcium / vitamin d |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Raloxifene is not a hormone but it mimics estrogen and may be used to treat osteoporosis in postmenopausal women or to lower the risk of invasive breast cancer in women with osteoporosis. Hot... View more |
Prescription only
Alendronate helps to reduce the risk of fracture in people with osteoporosis and some other bone conditions. Dosage instructions, including remaining upright for at least 30 minutes and taking with a... View more |
Over-the-counter
Prescribed for Osteoporosis, Dietary Supplementation. Calcium / vitamin d may also be used for purposes not listed in this medication guide. |
Related suggestions Osteoporosis
|
|||||||||||||||
| More about Raloxifene | More about Alendronate | More about Calcium / vitamin d | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Raloxifene has an average rating of 5.8 out of 10 from a total of 18 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 35% reported a negative effect. |
Alendronate has an average rating of 2.7 out of 10 from a total of 182 ratings on Drugs.com. 17% of reviewers reported a positive effect, while 80% reported a negative effect. |
Calcium / vitamin d has an average rating of 7.1 out of 10 from a total of 11 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Raloxifene prices |
View all Alendronate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Evista | Binosto, Fosamax | Calcarb with D, Calcet, Calcet Petites, Calcio Del Mar, Calcitrate with D, Calcium 600 D, Caltrate 600 with D Plus Soy, Caltrate 600+D, Caltrate Colon Health, Caltrate Gummy Bites, Caltro with Vitamin D, Calvite P, Chewable Calcium with Vitamin D, Citracal + D, Citracal Calcium Gummies, Citracal Calcium Pearls, Citracal Maximum, Citracal Petites, Citracal Plus Heart Health, Citracal Regular, Citracal Regular 250 mg + D, Citracal Slow Release 1200, Citrus Calcium with Vitamin D, Dical Captabs, Dical-D, Dicalphos plus D, Os-Cal 500 Chewable, Os-Cal Calcium+D3, Os-Cal Extra D3, Oysco 500 with D, Oyster Shell Calcium with Vitamin D, Oyster-D, Oystercal-D, Posture-D H/P, Risacal-D, UPCal D, Wellesse Liquid Calcium with Vitamin D View more | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
27.7 hours |
N/A |
N/A |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 45 drugs are known to interact with Raloxifene:
|
A total of 117 drugs are known to interact with Alendronate:
|
A total of 275 drugs are known to interact with Calcium / vitamin d:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
December 09, 1997 |
September 29, 1995 |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.